Holdings of Health Care Fund
Rydex Variable Trust ·132 declared positions · as of Mar 31, 2026
Original filing · Net assets 12.5M $ · Ten largest lines: 24.2 % of the equity sleeve
Sector breakdown
- Health care 65.9 %
- Materials 1.1 %
- Technology 0.7 %
- Consumer discretionary 0.6 %
- Industrials 0.5 %
- Unattributed 31.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 90.2 %
- IE 2.6 %
- GB 1.6 %
- DK 1.6 %
- CH 1.3 %
- NL 0.9 %
- IL 0.8 %
- DE 0.6 %
- BM 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 119 | 8.6M $ | 90.17 % |
| 2 | IE | 3 | 244.2K $ | 2.57 % |
| 3 | GB | 2 | 155K $ | 1.63 % |
| 4 | DK | 2 | 148.6K $ | 1.56 % |
| 5 | CH | 2 | 121K $ | 1.27 % |
| 6 | NL | 1 | 83.2K $ | 0.87 % |
| 7 | IL | 1 | 74K $ | 0.78 % |
| 8 | DE | 1 | 60K $ | 0.63 % |
| 9 | BM | 1 | 49.1K $ | 0.52 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 402 | 369.7K $ | 2.96 % |
| 2 | Johnson & Johnson | 1,342 | 328K $ | 2.63 % |
| 3 | AbbVie Inc | 1,190 | 258.8K $ | 2.07 % |
| 4 | Merck & Co Inc | 1,965 | 236.4K $ | 1.89 % |
| 5 | UnitedHealth Group Inc | 778 | 210.5K $ | 1.69 % |
| 6 | Thermo Fisher Scientific Inc | 384 | 188.7K $ | 1.51 % |
| 7 | Amgen Inc | 521 | 183.3K $ | 1.47 % |
| 8 | Abbott Laboratories | 1,707 | 175.3K $ | 1.40 % |
| 9 | Pfizer Inc | 6,235 | 175.1K $ | 1.40 % |
| 10 | Gilead Sciences Inc | 1,246 | 173.7K $ | 1.39 % |
| 11 | Intuitive Surgical Inc | 369 | 170.1K $ | 1.36 % |
| 12 | Danaher Corp | 810 | 153.6K $ | 1.23 % |
| 13 | Bristol-Myers Squibb Co | 2,519 | 152.8K $ | 1.22 % |
| 14 | Stryker Corp | 439 | 144.3K $ | 1.16 % |
| 15 | Vertex Pharmaceuticals Inc | 314 | 140.2K $ | 1.12 % |
| 16 | McKesson Corp | 152 | 131.5K $ | 1.05 % |
| 17 | Regeneron Pharmaceuticals, Inc. | 162 | 125.2K $ | 1.00 % |
| 18 | Boston Scientific Corp | 1,992 | 125K $ | 1.00 % |
| 19 | Cencora Inc | 397 | 124.7K $ | 1.00 % |
| 20 | CVS Health Corp | 1,723 | 123.7K $ | 0.99 % |
| 21 | Cigna Group/The | 418 | 111.5K $ | 0.89 % |
| 22 | Elevance Health Inc | 373 | 109.2K $ | 0.87 % |
| 23 | HCA Healthcare Inc | 228 | 107.9K $ | 0.86 % |
| 24 | Zoetis Inc | 790 | 93.4K $ | 0.75 % |
| 25 | Cardinal Health, Inc. | 436 | 92.1K $ | 0.74 % |
| 26 | IDEXX Laboratories Inc | 162 | 91K $ | 0.73 % |
| 27 | Alnylam Pharmaceuticals Inc | 275 | 91K $ | 0.73 % |
| 28 | Medtronic PLC | 1,045 | 90.5K $ | 0.73 % |
| 29 | Becton Dickinson & Co | 574 | 90.3K $ | 0.72 % |
| 30 | Edwards Lifesciences Corp | 1,115 | 89.3K $ | 0.71 % |
| 31 | Insmed Inc | 526 | 86K $ | 0.69 % |
| 32 | Novo Nordisk A/S | 2,333 | 85.7K $ | 0.69 % |
| 33 | ICON PLC | 767 | 84.9K $ | 0.68 % |
| 34 | Argenx SE | 114 | 83.2K $ | 0.67 % |
| 35 | AstraZeneca PLC | 422 | 83.2K $ | 0.67 % |
| 36 | Alkermes PLC | 2,307 | 81.6K $ | 0.65 % |
| 37 | BEONE MEDICINES LTD | 270 | 80.2K $ | 0.64 % |
| 38 | Agilent Technologies Inc | 687 | 78.3K $ | 0.63 % |
| 39 | Jazz Pharmaceuticals PLC | 411 | 77.7K $ | 0.62 % |
| 40 | GE HealthCare Technologies Inc | 1,083 | 77.1K $ | 0.62 % |
| 41 | ResMed Inc | 341 | 76.5K $ | 0.61 % |
| 42 | Waters Corp | 256 | 76.2K $ | 0.61 % |
| 43 | IQVIA Holdings Inc | 441 | 75.2K $ | 0.60 % |
| 44 | Teva Pharmaceutical Industries Ltd | 2,457 | 74K $ | 0.59 % |
| 45 | Natera Inc | 366 | 73.2K $ | 0.59 % |
| 46 | Mettler-Toledo International Inc | 58 | 73.1K $ | 0.59 % |
| 47 | United Therapeutics Corp | 123 | 72.9K $ | 0.58 % |
| 48 | GSK PLC | 1,301 | 71.8K $ | 0.57 % |
| 49 | Biogen Inc | 385 | 70.6K $ | 0.57 % |
| 50 | Royalty Pharma PLC | 1,445 | 69.3K $ | 0.56 % |
| 51 | Veeva Systems Inc | 394 | 69.2K $ | 0.55 % |
| 52 | Dexcom Inc | 1,038 | 65.2K $ | 0.52 % |
| 53 | STERIS PLC | 294 | 65K $ | 0.52 % |
| 54 | Novartis AG | 423 | 64.6K $ | 0.52 % |
| 55 | Labcorp Holdings Inc | 241 | 64.3K $ | 0.51 % |
| 56 | Humana Inc | 370 | 64.2K $ | 0.51 % |
| 57 | Ascendis Pharma A/S | 275 | 62.9K $ | 0.50 % |
| 58 | CRISPR Therapeutics AG | 1,315 | 62.6K $ | 0.50 % |
| 59 | Quest Diagnostics Inc | 313 | 61.3K $ | 0.49 % |
| 60 | Illumina Inc | 495 | 61K $ | 0.49 % |
| 61 | West Pharmaceutical Services Inc | 240 | 60.2K $ | 0.48 % |
| 62 | BioNTech SE | 675 | 60K $ | 0.48 % |
| 63 | Revolution Medicines Inc | 609 | 59.2K $ | 0.47 % |
| 64 | Alcon AG | 776 | 58.5K $ | 0.47 % |
| 65 | Moderna Inc | 1,137 | 57.8K $ | 0.46 % |
| 66 | Zimmer Biomet Holdings Inc | 621 | 56.2K $ | 0.45 % |
| 67 | Hologic Inc | 728 | 55K $ | 0.44 % |
| 68 | Incyte Corp | 578 | 54.4K $ | 0.44 % |
| 69 | Centene Corp | 1,627 | 53.3K $ | 0.43 % |
| 70 | Viatris Inc | 3,891 | 52.6K $ | 0.42 % |
| 71 | Bridgebio Pharma Inc | 694 | 51.5K $ | 0.41 % |
| 72 | Cooper Cos Inc/The | 710 | 50.8K $ | 0.41 % |
| 73 | Tenet Healthcare Corp | 268 | 50.6K $ | 0.40 % |
| 74 | Neurocrine Biosciences Inc | 377 | 49.7K $ | 0.40 % |
| 75 | Guardant Health Inc | 534 | 49.3K $ | 0.39 % |
| 76 | Roivant Sciences Ltd | 1,773 | 49.1K $ | 0.39 % |
| 77 | Insulet Corp | 233 | 48.9K $ | 0.39 % |
| 78 | Medpace Holdings Inc | 101 | 48.5K $ | 0.39 % |
| 79 | Ionis Pharmaceuticals Inc | 645 | 48.4K $ | 0.39 % |
| 80 | Elanco Animal Health Inc | 2,010 | 48.1K $ | 0.39 % |
| 81 | Align Technology Inc | 279 | 47.8K $ | 0.38 % |
| 82 | Exelixis Inc | 1,053 | 45.2K $ | 0.36 % |
| 83 | Revvity Inc | 501 | 43.9K $ | 0.35 % |
| 84 | BioMarin Pharmaceutical Inc | 771 | 43.6K $ | 0.35 % |
| 85 | Ensign Group Inc/The | 216 | 43.5K $ | 0.35 % |
| 86 | Charles River Laboratories International Inc | 252 | 43.5K $ | 0.35 % |
| 87 | Apellis Pharmaceuticals Inc | 1,067 | 42.9K $ | 0.34 % |
| 88 | Arrowhead Pharmaceuticals Inc | 684 | 42.9K $ | 0.34 % |
| 89 | Universal Health Services Inc | 231 | 41.3K $ | 0.33 % |
| 90 | Cytokinetics Inc | 624 | 41.1K $ | 0.33 % |
| 91 | Vaxcyte Inc | 684 | 39.7K $ | 0.32 % |
| 92 | Bio-Techne Corp | 756 | 39.5K $ | 0.32 % |
| 93 | Axsome Therapeutics Inc | 227 | 38.4K $ | 0.31 % |
| 94 | Masimo Corp | 215 | 38.2K $ | 0.31 % |
| 95 | Baxter International Inc | 2,268 | 38.1K $ | 0.31 % |
| 96 | Halozyme Therapeutics Inc | 589 | 38.1K $ | 0.30 % |
| 97 | HealthEquity Inc | 449 | 37.5K $ | 0.30 % |
| 98 | Madrigal Pharmaceuticals Inc | 70 | 36.6K $ | 0.29 % |
| 99 | Henry Schein Inc | 489 | 36K $ | 0.29 % |
| 100 | Protagonist Therapeutics Inc | 337 | 35.5K $ | 0.28 % |